Boston Hemp is releasing the latest cannabinoids to be discovered, such as THC-O, HHC and hemp-derived Delta-9 THC as a way to give consumers an alternative to marijuana. All of these alternatives are federally legal and provide new options for customers looking to explore the depths of what hemp has to offer.
With new cannabinoids being discovered constantly within the hemp industry, the market continues to expand its offerings rapidly. Boston Hemp is one of the largest wholesalers in the U.S. and is introducing customers to new cutting-edge natural alternatives as quickly as they are produced.
“Delta-8 is a great alternative, but our customer base is finding a unique pleasure in ordering HHC (hexahydrocannabinol), THC-O, CBD and hemp-derived Delta-9 gummies” said Brandon Gadles, CEO at Boston Hemp. “The prices are extremely affordable, and every product is 100% insured and lab tested for potency.”
HHC is a hydrogenated derivative of Delta-9 THC. THC-O is derived from Delta-8 THC. Legal Delta-9 THC is derived from hemp, but still contains a total level less than 0.3% by dry weight in each product. These newly released cannabinoids for the market are what customers expect to see from Boston Hemp and other industry leaders providing the newest options available.
The release of cannabinoids extracted from the hemp plant has catapulted the industry’s growth globally at a remarkable rate. The hemp market size was valued at $4.9 billion in 2019 but is now projected to reach $18.6 billion by 2027, registering a CAGR of 22.4% from 2021 to 2027, according to a new report published by Allied Market Research.
As more cannabinoids continue to be discovered and produced for the market, testing the products is of the utmost importance. All of Boston Hemp’s products are 100% insured and lab tested by third-party labs, ensuring accuracy and potency. The entire catalog of products, as well as wholesale requests, can be found on the company’s website.
